Lee KC - Search Results

1

Kang JS, Deluca PP, Lee KC. Kang JS, et al. Among authors: lee kc. Expert Opin Emerg Drugs. 2009 Jun;14(2):363-80. doi: 10.1517/14728210902907847. Expert Opin Emerg Drugs. 2009. PMID: 19453284 Review.

2

In vivo pharmacokinetics and pharmacodynamics of positional isomers of mono-PEGylated recombinant human granulocyte colony stimulating factor in rats.

Kang JS, Lee KC. Kang JS, et al. Among authors: lee kc. Biol Pharm Bull. 2013;36(7):1146-51. doi: 10.1248/bpb.b13-00132. Biol Pharm Bull. 2013. PMID: 23811564 Free article.

3

What is the future of PEGylated therapies?

Swierczewska M, Lee KC, Lee S. Swierczewska M, et al. Among authors: lee kc, lee s. Expert Opin Emerg Drugs. 2015;20(4):531-6. doi: 10.1517/14728214.2015.1113254. Epub 2015 Nov 19. Expert Opin Emerg Drugs. 2015. PMID: 26583759 Free PMC article.

4

Emerging PEGylated non-biologic drugs.

Park EJ, Choi J, Lee KC, Na DH. Park EJ, et al. Among authors: lee kc. Expert Opin Emerg Drugs. 2019 Jun;24(2):107-119. doi: 10.1080/14728214.2019.1604684. Epub 2019 Apr 19. Expert Opin Emerg Drugs. 2019. PMID: 30957581 Review.

5

Stability of PEGylated salmon calcitonin in nasal mucosa.

Na DH, Youn YS, Park EJ, Lee JM, Cho OR, Lee KR, Lee SD, Yoo SD, DeLuca PP, Lee KC. Na DH, et al. Among authors: lee kr, lee kc, lee sd, lee jm. J Pharm Sci. 2004 Feb;93(2):256-61. doi: 10.1002/jps.10537. J Pharm Sci. 2004. PMID: 14705183

6

PEGylation of octreotide: II. Effect of N-terminal mono-PEGylation on biological activity and pharmacokinetics.

Na DH, Lee KC, DeLuca PP. Na DH, et al. Among authors: lee kc. Pharm Res. 2005 May;22(5):743-9. doi: 10.1007/s11095-005-2590-y. Epub 2005 May 17. Pharm Res. 2005. PMID: 15906169

7

Direct determination of the peptide content in microspheres by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Na DH, DeLuca PP, Lee KC. Na DH, et al. Among authors: lee kc. Anal Chem. 2004 May 1;76(9):2669-73. doi: 10.1021/ac035477i. Anal Chem. 2004. PMID: 15117214

8

Preparation and stability of poly(ethylene glycol) (PEG)ylated octreotide for application to microsphere delivery.

Na DH, Murty SB, Lee KC, Thanoo BC, DeLuca PP. Na DH, et al. Among authors: lee kc. AAPS PharmSciTech. 2003 Dec 31;4(4):E72. doi: 10.1208/pt040472. AAPS PharmSciTech. 2003. PMID: 15198567 Free PMC article.

9

Monitoring of peptide acylation inside degrading PLGA microspheres by capillary electrophoresis and MALDI-TOF mass spectrometry.

Na DH, Youn YS, Lee SD, Son MW, Kim WB, DeLuca PP, Lee KC. Na DH, et al. Among authors: lee kc, lee sd. J Control Release. 2003 Oct 30;92(3):291-9. doi: 10.1016/s0168-3659(03)00366-3. J Control Release. 2003. PMID: 14568410

10

Pharmacokinetic and pharmacodynamic evaluation of site-specific PEGylated glucagon-like peptide-1 analogs as flexible postprandial-glucose controllers.

Chae SY, Chun YG, Lee S, Jin CH, Lee ES, Lee KC, Youn YS. Chae SY, et al. Among authors: lee kc, lee es, lee s. J Pharm Sci. 2009 Apr;98(4):1556-67. doi: 10.1002/jps.21532. J Pharm Sci. 2009. PMID: 18704955

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,245 results

Search Page